Hexoprenaline

Hexoprenaline

Identifiers
IUPAC name 4-[2-[6-([2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino)hexylamino]-1-hydroxyethyl]benzene-1,2-diol
CAS Number	3215-70-1
PubChem CID	3609
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H32N2O6
Molar mass	420.499 g/mol
3D model (JSmol)	Interactive image
SMILES C1=CC(=C(C=C1C(CNCCCCCCNCC(C2=CC(=C(C=C2)O)O)O)O)O)O

WikiDoc Resources for Hexoprenaline
Articles
Most recent articles on Hexoprenaline Most cited articles on Hexoprenaline Review articles on Hexoprenaline Articles on Hexoprenaline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hexoprenaline Images of Hexoprenaline Photos of Hexoprenaline Podcasts & MP3s on Hexoprenaline Videos on Hexoprenaline
Evidence Based Medicine
Cochrane Collaboration on Hexoprenaline Bandolier on Hexoprenaline TRIP on Hexoprenaline
Clinical Trials
Ongoing Trials on Hexoprenaline at Clinical Trials.gov Trial results on Hexoprenaline Clinical Trials on Hexoprenaline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hexoprenaline NICE Guidance on Hexoprenaline NHS PRODIGY Guidance FDA on Hexoprenaline CDC on Hexoprenaline
Books
Books on Hexoprenaline
News
Hexoprenaline in the news Be alerted to news on Hexoprenaline News trends on Hexoprenaline
Commentary
Blogs on Hexoprenaline
Definitions
Definitions of Hexoprenaline
Patient Resources / Community
Patient resources on Hexoprenaline Discussion groups on Hexoprenaline Patient Handouts on Hexoprenaline Directions to Hospitals Treating Hexoprenaline Risk calculators and risk factors for Hexoprenaline
Healthcare Provider Resources
Symptoms of Hexoprenaline Causes & Risk Factors for Hexoprenaline Diagnostic studies for Hexoprenaline Treatment of Hexoprenaline
Continuing Medical Education (CME)
CME Programs on Hexoprenaline
International
Hexoprenaline en Espanol Hexoprenaline en Francais
Business
Hexoprenaline in the Marketplace Patents on Hexoprenaline
Experimental / Informatics
List of terms related to Hexoprenaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.